Literature DB >> 25412956

Prognostic significance of lymph node ratio in esophageal cancer.

Nana Wang1, Yibin Jia, Jianbo Wang, Xintong Wang, Cihang Bao, Qingxu Song, Bingxu Tan, Yufeng Cheng.   

Abstract

N staging predicting esophageal cancer patient prognosis has been studied. Lymph node ratio, which is considered to show metastatic lymph node status more accurately, is found to have prognostic significance in several tumors. We investigated whether lymph node ratio (LNR) was associated with the prognosis of esophageal cancer in this study. Esophageal cancer patients who underwent esophagectomy at Qilu Hospital of Shandong University from January 2007 to December 2008 were studied. A total of 209 cases were evaluated in this study. The median disease-free survival (DFS) of this cohort was 35.2 months, and 5-year DFS rate was 32.1%. The median overall survival (OS) was 46.4 months, and 5-year OS rate was 40.0%. Kaplan-Meier survival analysis revealed that patients with LNR higher than 0.2 had significantly poorer DFS (p < 0.001) and OS (p < 0.001) than those with LNR less than 0.2. In a multivariate analysis, LNR was found to be an independent prognostic factor for DFS (p = 0.008, HR 1.863, 95% CI 1.180-2.942) and OS (p = 0.025, HR 1.708, 95% CI 1.068-2.731). N stage (p = 0.028, HR 1.626, 95% CI 1.055-2.506) was also found to be an independent prognostic factors for OS. Subgroups analysis revealed significant difference in OS and DFS rates between different LNR categories within the same N stages (p < 0.05) but not between different N stages within the same LNR category (p > 0.05). LNR was recognized as an independent factor in both OS and DFS in esophageal cancer. Besides, LNR showed a better prognostic value than N stage for esophageal cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25412956     DOI: 10.1007/s13277-014-2840-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

1.  Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?

Authors:  Zihui Tan; Guowei Ma; Haoxian Yang; Lanjun Zhang; Tiehua Rong; Peng Lin
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

2.  The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

Authors:  Nabil Rizk; Ennapadam Venkatraman; Bernard Park; Raja Flores; Manjit S Bains; Valerie Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

3.  Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG).

Authors:  Leila Sisic; Susanne Blank; Wilko Weichert; Dirk Jäger; Christoph Springfeld; Marcel Hochreiter; Markus Büchler; Katja Ott
Journal:  Langenbecks Arch Surg       Date:  2013-07-26       Impact factor: 3.445

4.  Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer.

Authors:  A R Davies; H Sandhu; A Pillai; P Sinha; F Mattsson; M J Forshaw; J A Gossage; J Lagergren; W H Allum; R C Mason
Journal:  Br J Surg       Date:  2014-02-24       Impact factor: 6.939

5.  Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.

Authors:  Jihyun Park; Byung Hyun Byun; Woo Chul Noh; Seung Sook Lee; Hyun-Ah Kim; Eun-Kyu Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Clin Nucl Med       Date:  2014-04       Impact factor: 7.794

6.  Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.

Authors:  Steven L Chen; Scott R Steele; John Eberhardt; Kangmin Zhu; Anton Bilchik; Alexander Stojadinovic
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

7.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

8.  Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.

Authors:  Attila Dubecz; Isabell Gall; Norbert Solymosi; Michael Schweigert; Jeffrey H Peters; Marcus Feith; Hubert J Stein
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

9.  Prediction of lymph node metastasis in patients with submucosa-invading early gastric cancer.

Authors:  Atsuo Shida; Shuichi Fujioka; Masahiko Kawamura; Naoto Takahashi; Yoshio Ishibashi; Koji Nakada; Norio Mitsumori; Nobuo Omura; Katsuhiko Yanaga
Journal:  Anticancer Res       Date:  2014-08       Impact factor: 2.480

10.  Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Authors:  Koen Talsma; Pieter van Hagen; Brechtje A Grotenhuis; Ewout W Steyerberg; Hugo W Tilanus; Jan J B van Lanschot; Bas P L Wijnhoven
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

View more
  12 in total

1.  Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection.

Authors:  Mingjian Yang; Hongdian Zhang; Zhao Ma; Lei Gong; Chuangui Chen; Peng Ren; Xiaobin Shang; Peng Tang; Hongjing Jiang; Zhentao Yu
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.

Authors:  Paolo Borghetti; Fernando Barbera; Marco Lorenzo Bonù; Francesca Trevisan; Stefano Ciccarelli; Paola Vitali; Marta Maddalo; Luca Triggiani; Nadia Pasinetti; Sara Pedretti; Bartolomea Bonetti; Gianluca Pariscenti; Andrea Tironi; Alberto Caprioli; Michela Buglione; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2016-05-26       Impact factor: 3.469

3.  The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.

Authors:  Xiao-Ling Xu; Wei-Hui Zheng; Shuang-Mei Zhu; An Zhao; Wei-Min Mao
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

4.  Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.

Authors:  San-Gang Wu; Jia-Yuan Sun; Li-Chao Yang; Juan Zhou; Feng-Yan Li; Qun Li; Huan-Xin Lin; Qin Lin; Zhen-Yu He
Journal:  Oncotarget       Date:  2015-11-03

5.  Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

Authors:  Yuming Zhao; Shengyi Zhong; Zhenhua Li; Xiaofeng Zhu; Feima Wu; Yanxing Li
Journal:  Oncotarget       Date:  2017-07-15

6.  Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.

Authors:  Peng Liu; Xianbin Zhang; Yuru Shang; Lili Lu; Fei Cao; Min Sun; Zhaohui Tang; Brigitte Vollmar; Peng Gong
Journal:  Oncotarget       Date:  2017-07-12

7.  The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.

Authors:  Vignesh Raman; Oliver K Jawitz; Norma E Farrow; Soraya L Voigt; Kristen E Rhodin; Chi-Fu J Yang; Megan C Turner; Thomas A D'Amico; David H Harpole; Betty C Tong
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 13.787

8.  Comparison of three lymph node staging systems in evaluating the prognosis of patients with pT3 esophageal squamous cell carcinoma.

Authors:  Di-Tian Liu; Lin-Shuo Wang; Yu-Ping Chen; Shao-Bin Chen
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

9.  Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Xiao-Feng Duan; Peng Tang; Xiao-Bin Shang; Hong-Jing Jiang; Zhen-Tao Yu
Journal:  Oncotarget       Date:  2017-07-28

10.  The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single-institution cohort.

Authors:  Hongdian Zhang; Wanyi Xiao; Peng Ren; Kai Zhu; Ran Jia; Yueyang Yang; Lei Gong; Zhentao Yu; Peng Tang
Journal:  Cancer Med       Date:  2021-07-09       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.